文献速递临床试验与 GCP流行病学与生物统计

维生素D补充对早产黑人婴儿反复喘息的影响:D-Wheeze随机临床试验

Effect of Vitamin D Supplementation on Recurrent Wheezing in Black Infants Who Were Born Preterm: The D-Wheeze Randomized Clinical Trial.
PubMed 文献 · JAMA · 2018-01-01

该随机临床试验纳入300名28至36周出生的黑人早产儿,比较持续补充维生素D(400 IU/d至矫正6月龄)与饮食限制补充对12月龄矫正年龄反复喘息的影响。结果显示持续补充组反复喘息发生率31.1%,饮食限制组41.8%,差异-10.7%(95%CI -27.4%至-2.9%),相对风险0.66(95%CI 0.47至0.94)。

要点

  • 持续补充维生素D可降低早产黑人婴儿12月龄矫正年龄反复喘息风险。
  • 持续补充组反复喘息发生率31.1%,低于饮食限制组的41.8%。
  • 上下呼吸道感染是两组最常见的不良事件,组间差异无统计学意义。

核心结论

  • 在早产黑人婴儿中,与饮食限制补充相比,持续补充维生素D可降低12月龄矫正年龄反复喘息的风险。

研究设计与样本

  • 随机临床试验纳入300名28至36周出生的黑人早产儿,2013年1月至2016年1月在美国4个中心入组,随访至2017年3月。
  • 随机化按中心和母乳暴露分层,持续补充组153例,饮食限制组147例。

主要发现

  • 持续补充组反复喘息发生率为31.1%,饮食限制组为41.8%,差异-10.7%(95%CI -27.4%至-2.9%),相对风险0.66(95%CI 0.47至0.94)。
  • 持续补充组上呼吸道感染84/153例(54.9%),饮食限制组83/147例(56.5%),差异-1.6%(95%CI -17.1%至7.0%)。
  • 持续补充组下呼吸道感染33/153例(21.6%),饮食限制组37/147例(25.2%),差异-3.6%(95%CI -16.4%至4.4%)。

关键数值与推荐

  • 持续补充方案:从能通过配方奶或母乳强化剂摄入200 IU/d胆钙化醇开始,给予400 IU/d胆钙化醇至矫正6月龄。
  • 饮食限制方案:同期给予安慰剂。

临床怎么用

  • 对于早产黑人婴儿,可考虑持续补充维生素D 400 IU/d至矫正6月龄以降低反复喘息风险。

局限性

  • 需进一步研究以更好理解维生素D补充对早产儿喘息的作用机制和长期影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Black infants born preterm face high rates of recurrent wheezing throughout infancy. Vitamin D supplementation has the potential to positively or negatively affect wheezing through modulation of the pulmonary and immune systems. OBJECTIVE: To assess the effectiveness of 2 vitamin D dosing strategies in preventing recurrent wheezing. DESIGN, SETTING, AND PARTICIPANTS: A randomized clinical trial enrolled 300 black infants born at 28 to 36 weeks' gestation between January 2013 and January 2016 at 4 sites in the United States, and followed them up through March 2017. Randomization was stratified by site and maternal milk exposure. INTERVENTIONS: Patients were enrolled prior to discharge from the neonatal intensive care unit or newborn nursery and received open-label multivitamin until they were consuming 200 IU/d of cholecalciferol from formula or fortifier added to human milk, after which they received either 400 IU/d of cholecalciferol until 6 months of age adjusted for prematurity (sustained supplementation) or placebo (diet-limited supplementation). One-hundred fifty three infants were randomized to the sustained group, and 147 were randomized to the diet-limited group. MAIN OUTCOMES AND MEASURES: Recurrent wheezing by 12 months' adjusted age was the primary outcome. RESULTS: Among 300 patients who were randomized (mean gestational age, 33 weeks; median birth weight, 1.9 kg), 277 (92.3%) completed the trial. Recurrent wheezing was experienced by 31.1% of infants in the sustained supplementation group and 41.8% of infants in the diet-limited supplementation group (difference, -10.7% [95% CI, -27.4% to -2.9%]; relative risk, 0.66 [95% CI, 0.47 to 0.94]). Upper and lower respiratory tract infections were among the most commonly reported adverse events. Upper respiratory infections were experienced by 84 of 153 infants (54.9%) in the sustained group and 83 of 147 infants (56.5%) in the diet-limited group (difference, -1.6% [95% CI, -17.1% to 7.0%]). Lower respiratory infections were experienced by 33 of 153 infants (21.6%) in the sustained group and 37 of 147 infants (25.2%) in the diet-limited group (difference, -3.6% [95% CI, -16.4% to 4.4%]). CONCLUSIONS AND RELEVANCE: Among black infants born preterm, sustained supplementation with vitamin D, compared with diet-limited supplementation, resulted in a reduced risk of recurrent wheezing by 12 months' adjusted age. Future research is needed to better understand the mechanisms and longer-term effects of vitamin D supplementation on wheezing in children born preterm. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01601847.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Hibbs AM, Ross K, Kerns LA, et al. Effect of Vitamin D Supplementation on Recurrent Wheezing in Black Infants Who Were Born Preterm: The D-Wheeze Randomized Clinical Trial. JAMA. 2018. PMID: 29800180. doi:10.1001/jama.2018.5729

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。